CorVel Co. (NASDAQ:CRVL) Chairman Sells $180,330.00 in Stock

Share on StockTwits

CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 3,000 shares of CorVel stock in a transaction on Wednesday, September 19th. The stock was sold at an average price of $60.11, for a total transaction of $180,330.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

V Gordon Clemons also recently made the following trade(s):

  • On Wednesday, October 10th, V Gordon Clemons sold 2,000 shares of CorVel stock. The stock was sold at an average price of $57.81, for a total transaction of $115,620.00.
  • On Wednesday, October 3rd, V Gordon Clemons sold 1,000 shares of CorVel stock. The stock was sold at an average price of $57.91, for a total transaction of $57,910.00.
  • On Friday, October 5th, V Gordon Clemons sold 2,587 shares of CorVel stock. The stock was sold at an average price of $57.76, for a total transaction of $149,425.12.
  • On Monday, October 1st, V Gordon Clemons sold 1,000 shares of CorVel stock. The stock was sold at an average price of $60.00, for a total transaction of $60,000.00.
  • On Thursday, September 27th, V Gordon Clemons sold 3,000 shares of CorVel stock. The stock was sold at an average price of $60.07, for a total transaction of $180,210.00.
  • On Monday, September 24th, V Gordon Clemons sold 1,000 shares of CorVel stock. The shares were sold at an average price of $58.54, for a total transaction of $58,540.00.
  • On Friday, September 21st, V Gordon Clemons sold 1,000 shares of CorVel stock. The shares were sold at an average price of $59.68, for a total transaction of $59,680.00.
  • On Monday, September 17th, V Gordon Clemons sold 1,000 shares of CorVel stock. The shares were sold at an average price of $60.13, for a total transaction of $60,130.00.
  • On Thursday, September 6th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $59.75, for a total transaction of $119,500.00.
  • On Wednesday, August 29th, V Gordon Clemons sold 2,500 shares of CorVel stock. The shares were sold at an average price of $60.22, for a total transaction of $150,550.00.

Shares of CRVL stock traded down $1.49 during mid-day trading on Friday, reaching $53.64. The stock had a trading volume of 46,187 shares, compared to its average volume of 33,160. CorVel Co. has a 52-week low of $46.45 and a 52-week high of $61.20. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of 29.68 and a beta of 0.61.

CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Tuesday, July 31st. The business services provider reported $0.62 earnings per share (EPS) for the quarter. CorVel had a net margin of 6.78% and a return on equity of 23.42%. The firm had revenue of $150.40 million for the quarter.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Legal & General Group Plc increased its position in shares of CorVel by 4.7% during the second quarter. Legal & General Group Plc now owns 21,784 shares of the business services provider’s stock valued at $1,173,000 after buying an additional 979 shares during the period. SG Americas Securities LLC increased its position in shares of CorVel by 66.0% during the second quarter. SG Americas Securities LLC now owns 3,446 shares of the business services provider’s stock valued at $186,000 after buying an additional 1,370 shares during the period. Raymond James & Associates increased its position in shares of CorVel by 17.4% during the second quarter. Raymond James & Associates now owns 13,495 shares of the business services provider’s stock valued at $729,000 after buying an additional 2,002 shares during the period. Dimensional Fund Advisors LP increased its position in shares of CorVel by 0.3% during the first quarter. Dimensional Fund Advisors LP now owns 791,983 shares of the business services provider’s stock valued at $40,035,000 after buying an additional 2,156 shares during the period. Finally, Piedmont Investment Advisors LLC purchased a new position in shares of CorVel during the second quarter valued at about $121,000. Institutional investors own 44.78% of the company’s stock.

Separately, BidaskClub cut shares of CorVel from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 9th.

CorVel Company Profile

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

Further Reading: Trading Penny Stocks

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply